Filings

1 document · 2 matches

1. ADCT ADC Therapeutics SA 10-K 2026-03-10

   Item 1A. Risk Factors

   material weaknesses or that may require prospective or retroactive changes to our consolidated financial statements, or identify other areas for further
   2 matches in this document Show context Copy citation